Laminar Pharma
Operator of a biopharmaceutical company intended to focus on the discovery of membrane-lipid therapy-based drugs. The company's drugs specifically interact with and modulate the activity of key signal...
Valuation
$168M
Market implied
Share Price
N/A
Total Raised
$46M
Last Round
N/A